Malignant Hyperthermia During Cardiac Surgery Successfully Treated by Deep Hypothermia Using Cardiopulmonary Bypass: A Case Report

2021 ◽  
Vol 15 (11) ◽  
pp. e01546
Author(s):  
Luuk R. van den Bersselaar ◽  
Markus W. Hollmann ◽  
Jeanette M. M. H. van den Goor ◽  
Jacobus A. Winkelman ◽  
Marc M. J. Snoeck ◽  
...  
Keyword(s):  
Cardiac Surgery ◽  
Case Report ◽  
Cardiopulmonary Bypass ◽  
Malignant Hyperthermia ◽  
Deep Hypothermia

Reversal of Ischemic Hepatitis after Cardiac Surgery under Cardiopulmonary Bypass: A Case Report

2020 ◽  
Vol 3 (2) ◽  
pp. 36-37
Author(s):  
Lokesh Shekher Jaiswal ◽  
Narendra Pandit ◽  
Jagat Narayan Prasad
Keyword(s):  
Cardiac Surgery ◽  
Case Report ◽  
Cardiopulmonary Bypass ◽  
Mitral Valve ◽  
Cardiogenic Shock ◽  
Valve Replacement ◽  
Fulminant Hepatic Failure ◽  
Hepatic Failure ◽  
Acute Hepatic Failure ◽  
Ischemic Hepatitis

Acute hepatic failure due to ischemic hepatitis is associated with high mortality. The safety of cardiopulmonary bypass in this setting is not fully described. Here we report a case of a 21-year-old female who developed an acute fulminant hepatic failure due to ischemic hepatitis following a cardiogenic shock. She underwent subsequent successful mitral valve replacement under cardiopulmonary bypass, thus providing an evidence of its safety in acute fulminant hepatic failure.

Beta-thalassemia in the paediatric cardiac surgery setting - a case report and literature review

Perfusion ◽  
2017 ◽  
Vol 33 (3) ◽  
pp. 232-234 ◽  
Author(s):  
Rebecca Richardson ◽  
Richard Issitt ◽  
Richard Crook
Keyword(s):  
Cardiac Surgery ◽  
Case Report ◽  
Cardiopulmonary Bypass ◽  
Literature Review ◽  
Beta Thalassemia ◽  
Blood Disorder ◽  
Paediatric Cardiac Surgery

Beta (β)-thalassemia is a blood disorder with an incidence of 1 in 100,000.1 This case report outlines a patient with β-thalassemia requiring cardiopulmonary bypass (CPB) and the measures taken to ensure an uneventful procedure.

Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass

2017 ◽  
Vol 22 (1) ◽  
pp. 95-99 ◽  
Author(s):  
Stephen Hall Sams ◽  
Stephen Revilla ◽  
David Lawrence Stahl
Keyword(s):  
Cardiac Surgery ◽  
Cardiopulmonary Bypass ◽  
Malignant Hyperthermia ◽  
Heart Surgery ◽  
Open Heart Surgery ◽  
Signs And Symptoms ◽  
Life Threatening ◽  
Cardiac Intensive Care ◽  
High Index Of Suspicion ◽  
Post Cardiac Surgery

Malignant hyperthermia (MH) is a rare but potentially life-threatening disorder encountered during general anesthesia. The use of cardiopulmonary bypass during cardiac surgery can obscure many of the cardinal signs and symptoms of MH. The development of postoperative MH following cardiac surgery is rare, but anesthesiologists and intensivists must maintain a high index of suspicion in order to make a prompt diagnosis. Initiation and tailored maintenance of MH therapy must also consider the complex physiologic changes of patients in the immediate post–cardiac surgery period. In this article, we present a case of the development of postoperative MH in the cardiac intensive care unit after elective open heart surgery with cardiopulmonary bypass.

scholarly journals Deep hypothermia combined with cardiopulmonary bypass for cardiac surgery in neonates and infants

1972 ◽  
Vol 64 (3) ◽  
pp. 422-429 ◽  
Author(s):  
Atsumi Mori ◽  
Ryusuke Muraoka ◽  
Yoshio Yokota ◽  
Yoshijumi Okamoto ◽  
Fumitaka Ando ◽  
...  
Keyword(s):  
Cardiac Surgery ◽  
Cardiopulmonary Bypass ◽  
Deep Hypothermia ◽  
Neonates And Infants

Metabolic changes in surface-induced deep hypothermia combined with cardiopulmonary bypass for cardiac surgery

1975 ◽  
Vol 5 (2) ◽  
pp. 73-83 ◽  
Author(s):  
Hiroshi Shida ◽  
Masami Morimoto ◽  
Tatsuyuki Seki ◽  
Koichi Inokawa
Keyword(s):  
Cardiac Surgery ◽  
Cardiopulmonary Bypass ◽  
Deep Hypothermia ◽  
Metabolic Changes
Sign in / Sign up

Export Citation Format

Share Document